| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| WPI has a current Overall Rating of C (Neutral). | 7 |
$25 |
| 25-Nov-2009 | New Constructs, LLC |
N/A
| WPI: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 25-Nov-2009 | Pechala's Reports | Lubomir Pechala | WATSON PHARMACEUTICALS INC (WPI=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 25-Nov-2009 | Stock Traders Daily | Thomas H. Kee Jr. | Trading Report for (WPI). A detailed Technical Analysis + Trading Plans for Day Trading, Swing Trading, and Long Term proactive investments in (WPI). | 5 |
$18 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 23-Nov-2009 | Wall Street Transcript ,The | The Wall St Transcript | MANAGEMENT TURNOVER REPORT - Watson Pharmaceuticals, Inc. (WPI) | 7 |
$50 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Watson Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
| 23-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for WPI | 13 |
$25 |
| 23-Nov-2009 | Market Edge |
N/A
| Market Edge Equity Research Report | 4 |
$10 |
| 22-Nov-2009 | Wright Reports |
N/A
| Wright Industry Averages: Health, Medicine and Pharmaceuticals (Global) | 148 |
$169 |
0.36% Nasdaq 
Research Reports
